TRxADE Health to acquire Scienture for $103m.

TRxADE Health, a health services technology company, agreed to acquire Scienture, a pharmaceutical company, for $103m. “We are very excited about the merger and believe the new combined company will provide the vehicle for our future expansion. Our mission at Scienture is in developing unique specialty product concepts and solutions that bring enhanced value to patients, caregivers and healthcare systems. Our assets in development are across therapeutics areas, indications and cater to different market segments. We are committed to serving patients, physicians and other healthcare stakeholders to attain better health outcomes,” Shankar Hariharan, Scienture President & CEO.